Deficiency of the immunoproteasome subunit β5i/LMP7 supports the anxiogenic effects of mild stress and facilitates cued fear memory in mice.


Journal

Brain, behavior, and immunity
ISSN: 1090-2139
Titre abrégé: Brain Behav Immun
Pays: Netherlands
ID NLM: 8800478

Informations de publication

Date de publication:
08 2019
Historique:
received: 21 08 2018
revised: 22 12 2018
accepted: 20 02 2019
pubmed: 24 2 2019
medline: 2 6 2020
entrez: 24 2 2019
Statut: ppublish

Résumé

Proteolysis as mediated by one of the major cellular protein degradation pathways, the ubiquitin-proteasome system (UPS), plays an essential role in learning and memory formation. However, the functional relevance of immunoproteasomes in the healthy brain and especially their impact on normal brain function including processes of learning and memory has not been investigated so far. In the present study, we analyzed the phenotypic effects of an impaired immunoproteasome formation using a β5i/LMP7-deficient mouse model in different behavioral paradigms focusing on locomotor activity, exploratory behavior, innate anxiety, startle response, prepulse inhibition, as well as fear and safety conditioning. Overall, our results demonstrate no strong effects of constitutive β5i/LMP7-deficiency on gross locomotor abilities and anxiety-related behavior in general. However, β5i/LMP7-deficient mice expressed more anxiety after mild stress and increased cued fear after fear conditioning. These findings indicate that the basal proper formation of immunoproteasomes and/or at least the expression of β5i/LMP7 in healthy mice seem to be involved in the regulation of anxiety and cued fear levels.

Identifiants

pubmed: 30797047
pii: S0889-1591(18)30497-5
doi: 10.1016/j.bbi.2019.02.018
pii:
doi:

Substances chimiques

LMP7 protein EC 3.4.25.1
Proteasome Endopeptidase Complex EC 3.4.25.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

35-43

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Xenia Gorny (X)

Institute for Molecular and Clinical Immunology, Otto-von-Guericke University Magdeburg, Germany.

Paula Säring (P)

Institute for Pharmacology and Toxicology, Otto-von-Guericke University Magdeburg, Germany.

Jorge R Bergado Acosta (JR)

Institute for Pharmacology and Toxicology, Otto-von-Guericke University Magdeburg, Germany; Center for Behavioral Brain Sciences, Otto-von-Guericke University Magdeburg, Germany.

Evelyn Kahl (E)

Institute for Pharmacology and Toxicology, Otto-von-Guericke University Magdeburg, Germany.

Malgorzata H Kolodziejczyk (MH)

Institute for Pharmacology and Toxicology, Otto-von-Guericke University Magdeburg, Germany.

Clemens Cammann (C)

Institute for Molecular and Clinical Immunology, Otto-von-Guericke University Magdeburg, Germany; Friedrich Loeffler Institute for Medical Microbiology, University Medicine, University Greifswald, Greifswald, Germany.

Kerstin E A Wernecke (KEA)

Institute for Pharmacology and Toxicology, Otto-von-Guericke University Magdeburg, Germany; Center for Behavioral Brain Sciences, Otto-von-Guericke University Magdeburg, Germany.

Dana Mayer (D)

Institute for Pharmacology and Toxicology, Otto-von-Guericke University Magdeburg, Germany.

Peter Landgraf (P)

Institute for Pharmacology and Toxicology, Otto-von-Guericke University Magdeburg, Germany.

Ulrike Seifert (U)

Institute for Molecular and Clinical Immunology, Otto-von-Guericke University Magdeburg, Germany; Friedrich Loeffler Institute for Medical Microbiology, University Medicine, University Greifswald, Greifswald, Germany.

Daniela C Dieterich (DC)

Institute for Pharmacology and Toxicology, Otto-von-Guericke University Magdeburg, Germany; Center for Behavioral Brain Sciences, Otto-von-Guericke University Magdeburg, Germany. Electronic address: daniela.dieterich@med.ovgu.de.

Markus Fendt (M)

Institute for Pharmacology and Toxicology, Otto-von-Guericke University Magdeburg, Germany; Center for Behavioral Brain Sciences, Otto-von-Guericke University Magdeburg, Germany. Electronic address: markus.fendt@med.ovgu.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH